Mitoguazone [mitoguazon]
topical
- Terms
-
MGBG
NSC-32946
-
Methyl-gag
Methylglyoxal Bis(guanylhydrazone)
MGBG
NSC-32946
Persistent link
https://www.medvik.cz/link/D008935
Definition
Antineoplastic agent effective against myelogenous leukemia in experimental animals. Also acts as an inhibitor of animal S-adenosylmethionine decarboxylase.
- DUI
- D008935 MeSH Browser
- CUI
- M0013946
- CAS
- Hydrazinecarboximidamide, 2,2'-(1-methyl-1,2-ethanediylidene)bis-
- Previous indexing
- Hydrazones (1973-1974); Amidines (1973-1974); Glyoxal (1973-1974)
- History note
- 86(75); was see under GUANIDINES 1975-85
- Public note
- 86; was see under GUANIDINES 1975-85
Allowable subheadings
- AD
- administration & dosage
- AE
- adverse effects
- AG
- agonists
- AA
- analogs & derivatives
- AN
- analysis
- AI
- antagonists & inhibitors
- BL
- blood
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry
- CL
- classification
- EC
- economics
- HI
- history
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism
- PK
- pharmacokinetics
- PD
- pharmacology
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use
- TO
- toxicity
- UR
- urine
...
Occurrences in Medvik records
D
Chemicals and Drugs
D02.078.370.120
Bethanidine
D02.078.370.435
Guanabenz
D02.078.370.500
Impromidine
D02.078.370.570
Methylguanidine
D02.078.370.600
Mitoguazone